| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/18/2004 | EP1446099A1 Injectable depot composition |
| 08/18/2004 | EP1446088A2 Intraorally disintegrating valdecoxib compositions prepared by fluid bed granulation process |
| 08/18/2004 | EP1446015A1 Remodeling of tissues and organs |
| 08/18/2004 | EP1343434A4 Methods for contemporaneous administration of levamisole and 5-fluorouracil |
| 08/18/2004 | EP1294366B1 Pharmaceutical compounds for treating copd |
| 08/18/2004 | EP1268429B1 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 08/18/2004 | EP1228079B1 Novel fucosylated oligosaccharides and process for their preparation |
| 08/18/2004 | EP1212309B1 Caspase inhibitor |
| 08/18/2004 | EP1189924B1 Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease |
| 08/18/2004 | EP1187814B1 5-phenyl-pyrimidine derivatives |
| 08/18/2004 | EP1179343B1 Remedies for diabetes comprising 2-(n-cyanoimino)thiazolidine-4-one derivatives |
| 08/18/2004 | EP1175397B1 3,3-substituted indoline derivatives |
| 08/18/2004 | EP1140119B1 Use OF LOW MOLECULAR WEIGHT HEPARIN for the prevention and/or treatment of motoneuronal diseases |
| 08/18/2004 | EP1045637A4 Decorated red blood cells |
| 08/18/2004 | EP1037636A4 Inhibition of membrane-associated viral replication |
| 08/18/2004 | EP1030857B1 Adenosine a1 receptor agonists |
| 08/18/2004 | EP1030856B1 Adenosine a1 receptor agonists |
| 08/18/2004 | EP0977856B1 Lag-3 splice variants |
| 08/18/2004 | EP0944599B1 Triarylethanes useful as pde iv inhibitors |
| 08/18/2004 | EP0909171B1 Use of l-acetylcarnitine, l-isovalerylcarnitine, l-propionylcarnitine for increasing the levels of igf-1 |
| 08/18/2004 | EP0827544B1 Multimeric proteins |
| 08/18/2004 | EP0820507B1 Ndf peptides |
| 08/18/2004 | EP0744950B1 Agent for prophylaxis and treatment of thromboxane a2 mediated diseases |
| 08/18/2004 | EP0706387B1 New procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis |
| 08/18/2004 | EP0663014B1 Dna encoding human alpha 1 adrenergic receptors and uses thereof |
| 08/18/2004 | EP0471011B2 HUMAN LACTOFERRIN cDNA SEQUENCE |
| 08/18/2004 | CN1522263A Novel galactosylceramide analogs and beta-glucocerebrosidase activators, external skin preparations and method of activating beta-glucocerebrosidase using the analogs |
| 08/18/2004 | CN1522258A Novel 4-amino-5,6-substituted thiopheno 2,3-d]pyrimidines |
| 08/18/2004 | CN1522256A Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharamaceutical compositions comprising them and their use as a medicine |
| 08/18/2004 | CN1522254A Immunomodulating compounds |
| 08/18/2004 | CN1522253A Novel heterocyclic derivatives and medicinal use thereof |
| 08/18/2004 | CN1522252A Dihydro-benzo(b)(1,4)diazepin-2-one derivatives as mglur2 antagonists I |
| 08/18/2004 | CN1522250A Cyclic diamine compound having five-membered cyclic group |
| 08/18/2004 | CN1522248A Novel butadiene derivatives, process for preparation of the same and intermediates for the synthesis thereof |
| 08/18/2004 | CN1522246A Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (MTP) and/or apolipoprotein b (APO B) secretion |
| 08/18/2004 | CN1522245A Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obestity and type II diabetes |
| 08/18/2004 | CN1522159A Interferon formulations |
| 08/18/2004 | CN1522151A Modified fvii in treatment of ards |
| 08/18/2004 | CN1522146A Use of cyclopamine in the treatment of psoriasis |
| 08/18/2004 | CN1522142A Potassium channel opener |
| 08/18/2004 | CN1521189A Analogs of parathyroid hormone |
| 08/18/2004 | CN1520834A Medical composition possessing function of refreshing oneself, senium-resistant, reinforcing body fluid and nourishing the blood, nourishing liver |
| 08/18/2004 | CN1520819A Substituted morphinan and uses of its pharmaceutically acceptable salt |
| 08/18/2004 | CN1162445C Jackfruit cycloalkane triterpenic saponin compound and its application in the treatment of cardiovascular disease |
| 08/18/2004 | CN1162429C Tricyclic vasopressin agonists |
| 08/18/2004 | CN1162427C Amine derivatives compounds as medicament and its salts and esters used for medicine |
| 08/18/2004 | CN1162425C 4-hydroxyl-piperidine derivative |
| 08/18/2004 | CN1162424C Quinoline-4-yl derivative II |
| 08/18/2004 | CN1162414C Benzothiadiazine derivs., preparation method and pharmaceutical compositions contg. same |
| 08/18/2004 | CN1162408C Process for preparing oxazolines from tetrahydrofurans |
| 08/18/2004 | CN1162180C Kidney failure treating medicine |
| 08/18/2004 | CN1162166C Traditional Chinese medicine preparation for regulating adolescence course and improving bone growth of sexual precocity child |
| 08/18/2004 | CN1162154C Lauryl piperazine, lauryl diethanolamine and the application of their derivatives in extracorporeal marrow purification |
| 08/18/2004 | CN1162152C Remedies for diabetes |
| 08/17/2004 | US6778854 Methods of indirectly stimulating the vagus nerve with an electrical field |
| 08/17/2004 | US6777577 Anticancer agents; antidiabetic agents, anticholesterol agents, cardiovascular disorders, osteoporosis |
| 08/17/2004 | US6777557 Method and composition for rejuvenating cells, tissues organs, hair and nails |
| 08/17/2004 | US6777555 3-(optionally hydroxyl)-4-(cyclopropylcarbonyl)-cumene intermediate |
| 08/17/2004 | US6777544 Polyamide nucleic acid derivatives and agents and processes for preparing them |
| 08/17/2004 | US6777543 13-methyl erythromycin derivatives |
| 08/17/2004 | US6777444 Nordihydroguaiaretic acid; anticancer agents, viricides |
| 08/17/2004 | US6777443 For therapy of cardiovascular disorders in mammals; for inhibiting both angiotensin converting enzyme and neutral endopeptidase in mammals |
| 08/17/2004 | US6777441 For therapy and prophylaxis |
| 08/17/2004 | US6777440 For therapy of hiv infections; for therapy of aids or arc |
| 08/17/2004 | US6777438 Inhibitors of farnesyl protein transferase |
| 08/17/2004 | US6777437 Antidepressants, anxiolytic agents. sexual disorders |
| 08/17/2004 | US6777434 Thiazolidine-4-one derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 08/17/2004 | US6777430 Phenylsulphonyl derivatives as 5-HT receptor ligands |
| 08/17/2004 | US6777424 Administering to a patient having or at risk of having osteoarthritis, a therapeutically effective amount of an bicyclicaromatic or heteroaromatic compound containing amine and hydroxy groups |
| 08/17/2004 | US6777421 Treating a condition selected from the group consisting of anxiety, depression, substance abuse, neuropathic pain, acute pain, migraine, asthma, cough and improved cognition, in a subject in need thereof comprising administering a compound |
| 08/17/2004 | US6777419 Pyrazolo [4,3-d]pyrimidines |
| 08/17/2004 | US6777418 For treating or preventing emphysema, cancer and dermatological disorders |
| 08/17/2004 | US6777417 3-(4,5,6,7-tetrahydroindol-2-ylmethylidiene-2-indolinone derivatives as kinase inhibitors |
| 08/17/2004 | US6777415 Administering (1) a farnesyl protein transferase inhibitor and (2) a tyrosine kinase inhibitor. |
| 08/17/2004 | US6777414 Nitrogen-containing heterocyclic compounds and benamide compounds and drugs containing the same |
| 08/17/2004 | US6777408 Pyrido-thieno-diazepines method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines |
| 08/17/2004 | US6777403 Method and structure for inhibiting activity of serine elastases |
| 08/17/2004 | US6777395 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase of hepatitis C virus |
| 08/17/2004 | US6777200 Kinesin motor modulators derived from the marine sponge Adocia |
| 08/17/2004 | US6777194 Monoclonal antibodies against human protein Mcm3, process for their production, and their use |
| 08/17/2004 | US6776978 Aerosol comprises particles comprising at least 10 percent by weight of an opioid, and wherein the opioid is not heroin; opiods include morphine, codeine, naltrexone, buprenorphine, fentanyl, nalbuphine, naloxone, etc. |
| 08/17/2004 | US6776796 Antiinflammatory drug and delivery device |
| 08/17/2004 | CA2334257C Treatment of osteoporosis with ep2/ep4 receptor selective agonists |
| 08/17/2004 | CA2292921C Aryl carboxylic acid and tetrazole derivatives |
| 08/17/2004 | CA2254658C New naphtalene compounds, their method of preparation and pharmaceutical compositions containing these compounds |
| 08/17/2004 | CA2236582C Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives |
| 08/17/2004 | CA2212010C Extracts of shark cartilage, process of production and uses thereof |
| 08/17/2004 | CA2122908C Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones |
| 08/12/2004 | WO2004067741A1 Transcriptional activator |
| 08/12/2004 | WO2004067554A2 Compositions and methods of tolerizing a primate to an antigen |
| 08/12/2004 | WO2004067542A1 Oligosaccharide derivative |
| 08/12/2004 | WO2004067535A1 Thienopyrimidine compounds and use thereof |
| 08/12/2004 | WO2004067526A1 CRYSTAL OF (23S)-1α-HYDROXY-27-NOR-25-METHYLENEVITAMIN D3-26,23-LACTONE AND PROCESS FOR PRODUCING THE SAME |
| 08/12/2004 | WO2004067509A1 Compound inhibiting dipeptidyl peptidase iv |
| 08/12/2004 | WO2004067504A1 2-substituted vitamin d derivative |
| 08/12/2004 | WO2004067037A1 Intestinal environment controlling agent for oral use and normal intestinal flora growing kit for oral use |
| 08/12/2004 | WO2004067019A1 Antiallergic agent containing ground lotus or lotus extract |
| 08/12/2004 | WO2004067017A1 Feng-you-jing spray |
| 08/12/2004 | WO2004067015A1 Auxiliary agent to be used in cancer therapy by dielectric heating and cancer therapy method |
| 08/12/2004 | WO2004067008A1 Receptor agonists |